Final results of a phase 2, open-label study of indisulam,...

  • Main
  • 2018 / 04
  • Final results of a phase 2, open-label study of indisulam,...

Final results of a phase 2, open-label study of indisulam, idarubicin, and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome

Assi, Rita, Kantarjian, Hagop M., Kadia, Tapan M., Pemmaraju, Naveen, Jabbour, Elias, Jain, Nitin, Daver, Naval, Estrov, Zeev, Uehara, Taisuke, Owa, Takashi, Cortes, Jorge E., Borthakur, Gautam
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Cancer
DOI:
10.1002/cncr.31398
Date:
April, 2018
File:
PDF, 525 KB
english, 2018
Conversion to is in progress
Conversion to is failed